• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥美沙坦相关肠病:临床与组织学发现综述

Olmesartan-Associated Enteropathy: A Review of Clinical and Histologic Findings.

作者信息

Choi Eun-Young Karen, McKenna Barbara J

机构信息

From the Department of Pathology, University of Michigan, Ann Arbor.

出版信息

Arch Pathol Lab Med. 2015 Oct;139(10):1242-7. doi: 10.5858/arpa.2015-0204-RA.

DOI:10.5858/arpa.2015-0204-RA
PMID:26414468
Abstract

Olmesartan is an antihypertensive medication belonging to the angiotensin II receptor blocker class of drugs that has recently been associated with severe enteropathy. Olmesartan-associated enteropathy is uncommon and may be difficult to recognize because of its clinical and histologic similarities to other clinical entities, including celiac sprue and autoimmune enteropathy. The purpose of this article is to review the clinical and histologic findings of olmesartan-associated enteropathy that have been reported in the literature and to discuss clinical entities to consider in the differential diagnosis of olmesartan-associated enteropathy.

摘要

奥美沙坦是一种降压药物,属于血管紧张素II受体阻滞剂类药物,最近被发现与严重肠病有关。奥美沙坦相关肠病并不常见,由于其临床和组织学表现与其他临床疾病(包括乳糜泻和自身免疫性肠病)相似,可能难以识别。本文的目的是回顾文献中报道的奥美沙坦相关肠病的临床和组织学表现,并讨论在奥美沙坦相关肠病鉴别诊断中需要考虑的临床疾病。

相似文献

1
Olmesartan-Associated Enteropathy: A Review of Clinical and Histologic Findings.奥美沙坦相关肠病:临床与组织学发现综述
Arch Pathol Lab Med. 2015 Oct;139(10):1242-7. doi: 10.5858/arpa.2015-0204-RA.
2
Olmesartan-Induced Enteropathy.奥美沙坦所致小肠病
Methodist Debakey Cardiovasc J. 2016 Oct-Dec;12(4):230-232. doi: 10.14797/mdcj-12-4-230.
3
[Three cases of severe chronic diarrhea with a rare cause and a simple therapy].[三例病因罕见且治疗简单的严重慢性腹泻病例]
Internist (Berl). 2018 Sep;59(9):961-966. doi: 10.1007/s00108-018-0417-2.
4
[Olmesartan-associated enteropathy: attention to an emerging iatrogenic phenomenon].[奥美沙坦相关肠病:关注一种新出现的医源性现象]
An Sist Sanit Navar. 2017 Aug 31;40(2):291-294. doi: 10.23938/ASSN.0021.
5
Olmesartan-induced enteropathy treated with budesonide.布地奈德治疗奥美沙坦所致肠病
Acta Gastroenterol Belg. 2019 Apr-Jun;82(2):319-321.
6
Olmesartan-associated Enteropathy with Acute Kidney Injury.奥美沙坦相关肠病伴急性肾损伤
Korean J Gastroenterol. 2022 Mar 25;79(3):130-134. doi: 10.4166/kjg.2022.007.
7
[Olmesartan therapy and enteropathy: About two cases and review of the literature].[奥美沙坦治疗与肠病:两例病例及文献综述]
Rev Med Interne. 2019 Feb;40(2):112-116. doi: 10.1016/j.revmed.2018.08.006. Epub 2018 Aug 31.
8
Sprue-like enteropathy associated with olmesartan - broadening the differential diagnosis of enteropathy.与奥美沙坦相关的类口炎性腹泻样小肠病——拓宽小肠病的鉴别诊断范围
Aliment Pharmacol Ther. 2014 Dec;40(11-12):1362-3. doi: 10.1111/apt.13000.
9
An emerging issue in differential diagnosis of diarrhea: sprue-like enteropathy associated with olmesartan.腹泻鉴别诊断中的一个新问题:与奥美沙坦相关的类口炎性腹泻样小肠病。
Scand J Gastroenterol. 2016 Mar;51(3):378-80. doi: 10.3109/00365521.2015.1083051. Epub 2015 Sep 11.
10
[Acute renal failure secondary to diarrhea due to sprue like-enteropathy associated with olmesartan].[因与奥美沙坦相关的口炎性腹泻样肠病导致腹泻继发的急性肾衰竭]
Gastroenterol Hepatol. 2015 Oct;38(8):514-5. doi: 10.1016/j.gastrohep.2014.11.007. Epub 2014 Dec 18.

引用本文的文献

1
Atypical Rapid Onset of Olmesartan-Induced Enteropathy with Recurrence After Rechallenging.奥美沙坦诱导的肠病非典型快速发作及再次激发后复发
Diseases. 2025 Jul 18;13(7):223. doi: 10.3390/diseases13070223.
2
Diagnostic Challenges in Enteropathies: A Histopathological Review.肠病的诊断挑战:组织病理学综述
Diagnostics (Basel). 2025 Jun 13;15(12):1511. doi: 10.3390/diagnostics15121511.
3
Olmesartan-induced gastritis with no lower gastrointestinal symptoms: A case report.奥美沙坦诱发的胃炎且无下消化道症状:一例报告
DEN Open. 2025 Apr 29;6(1):e70124. doi: 10.1002/deo2.70124. eCollection 2026 Apr.
4
Effect of 2 Forms of Tenofovir on Duodenal Enterocytes-A Hypothesis for Different Effect of Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide on Body Weight and Plasma Lipids.两种形式的替诺福韦对十二指肠肠细胞的影响——关于富马酸替诺福韦二吡呋酯和替诺福韦艾拉酚胺对体重和血浆脂质产生不同影响的一种假说
Clin Infect Dis. 2025 Feb 24;80(2):381-388. doi: 10.1093/cid/ciae374.
5
A Rare Case of Olmesartan-Associated Enteropathy Successfully Managed With Steroid Taper.一例成功通过逐渐减量使用类固醇治疗的奥美沙坦相关性肠病罕见病例。
Cureus. 2023 Jul 9;15(7):e41604. doi: 10.7759/cureus.41604. eCollection 2023 Jul.
6
Olmesartan-Induced Enteropathy: A Case Report.奥美沙坦所致小肠病:一例报告
Cureus. 2023 Jun 12;15(6):e40342. doi: 10.7759/cureus.40342. eCollection 2023 Jun.
7
The histological spectrum of ARB-induced gastritis.ARB 诱导性胃炎的组织学谱。
Histopathology. 2022 Nov;81(5):653-660. doi: 10.1111/his.14766. Epub 2022 Aug 23.
8
A Case of Sprue-like Enteropathy Associated With Valsartan and Irbesartan.缬沙坦和厄贝沙坦相关的类口炎性腹泻样小肠病一例
J Neurogastroenterol Motil. 2022 Apr 30;28(2):327-329. doi: 10.5056/jnm21161.
9
Severe spruelike enteropathy and collagenous colitis caused by olmesartan.奥米沙坦导致的严重类脂性肠病和胶原性结肠炎。
BMC Gastroenterol. 2021 Sep 23;21(1):350. doi: 10.1186/s12876-021-01926-y.
10
Coeliac disease enteropathy and symptoms may be aggravated by angiotensin receptor blockers in patients on a gluten-free diet.麸质无饮食患者的血管紧张素受体阻滞剂可能会加重乳糜泻肠病和症状。
United European Gastroenterol J. 2021 Oct;9(8):973-979. doi: 10.1002/ueg2.12117. Epub 2021 Jun 29.